Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
Inactivation of the cyclin-dependent kinase inhibitors p16INK4A and p15INK4B are frequent alterations in neoplasia, often resulting from homozygous deletion or promoter region h...